# Comparison of 3 Diagnostic Strategies of PE: Planar V/Q Scan, CTPA, and V/Q SPECT.

Study · id `cardio:ct-nct02983760` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02983760](<https://clinicaltrials.gov/study/NCT02983760>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02983760

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 611 participants.

## Technical summary

Registry record NCT02983760. Randomized; no masking; primary purpose diagnostic. Start 2017-04-10 (actual); primary completion 2024-12-17 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 611 participants (enrolled count; ClinicalTrials.gov record NCT02983760, source copy `cardio:ctgov-nct02983760-2025-02-05`, retrieved 2026-10-31)
- Started: 2017-04-10 (actual) (ClinicalTrials.gov record NCT02983760, source copy `cardio:ctgov-nct02983760-2025-02-05`, retrieved 2026-10-31)
- Primary completion: 2024-12-17 (actual) (ClinicalTrials.gov record NCT02983760, source copy `cardio:ctgov-nct02983760-2025-02-05`, retrieved 2026-10-31)
- Completion: 2024-12-17 (actual) (ClinicalTrials.gov record NCT02983760, source copy `cardio:ctgov-nct02983760-2025-02-05`, retrieved 2026-10-31)
- Countries: Canada; France; Switzerland (ClinicalTrials.gov record NCT02983760, source copy `cardio:ctgov-nct02983760-2025-02-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02983760-2025-02-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Comparison of 3 Diagnostic Strategies of PE: Planar V/Q Scan, CTPA, and V/Q SPECT.
- Acronym: SPECTACULAR
- Condition: Pulmonary Embolism
- Intervention (Device): Planar V/Q-based strategy
- Intervention (Device): CTPA-based strategy
- Intervention (Device): V/Q SPECT-based strategy
- Lead sponsor: University Hospital, Brest
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: University Hospital, Brest (`cardio:org-university-hospital-brest`)

## Provenance

Content hash: a2fab75e43a3fac3ceb4bf4f5c1750e6418c24049bf324701a755c370af82c77
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
